Hümeyra Çelik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hümeyra Çelik has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Ayhan Çetinkaya
Department of Physiology, Bolu Abant İzzet Baysal University Faculty of Medicine, Bolu,Turkey
7 shared publications - Şeyda Karabörk
Bolu Abant İzzet Baysal University
4 shared publications - Canan Akünal Türel
Department of Neurology, Faculty of Medicine, Bolu Abant Izzet Baysal University, Bolu, Turkey
3 shared publications - Ibrahim Ethem Torun
Department of Physiology, Faculty of Medicine, Bolu Abant Izzet Baysal University, Bolu, Turkey
3 shared publications - İdRis Türel
Bolu Abant İzzet Baysal University
2 shared publications - İlHan Çelik
Department of Orthopaedics and Traumatology, Alanya Alaaddin Keykubat University Training and Research Hospital, Antalya, Türkiye
2 shared publications
Latest Publications
- 7 October 2026
- Published by Wiley in European Journal of Neuroscience
- Vol. 64 (7) , e70705
Insulin Enhances Nitroglycerin‐Induced Hyperalgesia Through Insulin‐Responsive Receptor Signalling Involving the Trigeminovascular System and Meningeal Mast Cells
Migraine headache prevalence is lower in patients with diabetes, but the underlying mechanisms remains unclear. This study explored the influences of hyperglycemia, insulin and insulin receptor (IR)/insulin‐like growth factor 1 receptor (IGF‐1R)–related signalling on migraine‐related mechanisms in in vivo and ex vivo rat models. In in vivo experiments, migraine‐relevant responses were induced by systemic injection of nitroglycerin (NTG), whereas hyperglycemia was induced by streptozotocin (STZ). The effects of hyperglycemia, insulin and the dual IR/IGF‐1R inhibitor BMS‐754807 were investigated. In ex vivo experiments, the effects of insulin and BMS on basal and capsaicin‐induced calcitonin gene‐related peptide (CGRP) releases from migraine‐associated tissues (peripheral meningeal afferents and trigeminal ganglion, and central brainstem trigeminal nucleus) were directly tested. Mechanical hyperalgesia was evaluated by von‐Frey, CGRP and c‐Fos levels by ELISA and meningeal mast cells by toluidine‐blue staining. In in vivo NTG group, insulin further lowered the pain threshold and further enhanced CGRP and c‐fos concentrations in trigeminal tissues and mast cell activation in the meninges. Hyperglycemia alone or in the NTG‐treated group did not change these parameters. In ex vivo experiments, direct administration of insulin stimulated CGRP release in meningeal and trigeminal ganglion, but not trigeminal nucleus, tissues and further enhanced capsaicin‐stimulated CGRP release, confirming the in vivo effects. The in vivo and ex vivo effects of insulin were reversed by BMS. Hyperglycemia did not modify the NTG‐induced responses. However, insulin facilitates migraine‐related responses by enhancing trigeminal CGRP signalling and meningeal mast cell activation through IR and/or IGF‐1R‐related signalling. Modulation of insulin‐responsive IR/IGF‐1R–related signalling within the trigeminovascular system may represent a potential target for future therapeutic strategies.
- 7 October 2026
- Published by Wiley in European Journal of Neuroscience
- Vol. 64 (7) , e70705
Insulin Enhances Nitroglycerin‐Induced Hyperalgesia Through Insulin‐Responsive Receptor Signalling Involving the Trigeminovascular System and Meningeal Mast Cells
Migraine headache prevalence is lower in patients with diabetes, but the underlying mechanisms remains unclear. This study explored the influences of hyperglycemia, insulin and insulin receptor (IR)/insulin‐like growth factor 1 receptor (IGF‐1R)–related signalling on migraine‐related mechanisms in in vivo and ex vivo rat models. In in vivo experiments, migraine‐relevant responses were induced by systemic injection of nitroglycerin (NTG), whereas hyperglycemia was induced by streptozotocin (STZ). The effects of hyperglycemia, insulin and the dual IR/IGF‐1R inhibitor BMS‐754807 were investigated. In ex vivo experiments, the effects of insulin and BMS on basal and capsaicin‐induced calcitonin gene‐related peptide (CGRP) releases from migraine‐associated tissues (peripheral meningeal afferents and trigeminal ganglion, and central brainstem trigeminal nucleus) were directly tested. Mechanical hyperalgesia was evaluated by von‐Frey, CGRP and c‐Fos levels by ELISA and meningeal mast cells by toluidine‐blue staining. In in vivo NTG group, insulin further lowered the pain threshold and further enhanced CGRP and c‐fos concentrations in trigeminal tissues and mast cell activation in the meninges. Hyperglycemia alone or in the NTG‐treated group did not change these parameters. In ex vivo experiments, direct administration of insulin stimulated CGRP release in meningeal and trigeminal ganglion, but not trigeminal nucleus, tissues and further enhanced capsaicin‐stimulated CGRP release, confirming the in vivo effects. The in vivo and ex vivo effects of insulin were reversed by BMS. Hyperglycemia did not modify the NTG‐induced responses. However, insulin facilitates migraine‐related responses by enhancing trigeminal CGRP signalling and meningeal mast cell activation through IR and/or IGF‐1R‐related signalling. Modulation of insulin‐responsive IR/IGF‐1R–related signalling within the trigeminovascular system may represent a potential target for future therapeutic strategies.
- 22 July 2026
- Published by Taylor & Francis in International Journal of Environmental Health Research
- p. 1-10
An in vitro investigation on the effects of neonicotinoid pesticides on uterine contractility
The widespread use of pesticides has been a cornerstone of modern agriculture, yet their silent footprints on human health are only beginning to be uncovered. Among them, neonicotinoids represent a...
- 22 July 2026
- Published by Taylor & Francis in International Journal of Environmental Health Research
- p. 1-10
An in vitro investigation on the effects of neonicotinoid pesticides on uterine contractility
The widespread use of pesticides has been a cornerstone of modern agriculture, yet their silent footprints on human health are only beginning to be uncovered. Among them, neonicotinoids represent a...
- 31 March 2026
- Published by Ministry of Health, Ankara City Hospital in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
- Vol. 23 (1) , 49-53
Analysis of Laboratory and Obstetric Outcomes in Preeclampsia: A Comparative Study of Bolu and Şanlıurfa
Aim: The aim of this study is to compare the obstetric outcomes of preeclamptic pregnant women in two different centers.Material andMethod: In this retrospective study, biochemical, hemogram, and obstetric data of pregnant women who presented to obstetrics clinics due to preeclampsia in Şanlıurfa (n=363) and Bolu (n=72) were analyzed.Results: A total of 435 pregnant women diagnosed with preeclampsia were included in the study. No significant differences were observed between Şanlıurfa and Bolu in terms of age, hemoglobin levels, and mode of delivery. However, systolic (SBP) and diastolic (DBP) blood pressures, AST, ALT, gravidity, and parity were significantly higher in Şanlıurfa compared to Bolu. Although proteinuria was more frequently observed in Bolu, it was more severe in Şanlıurfa. Additionally, Rh antigen positivity was found to be more common in preeclamptic pregnancies.Conclusion: Our study demonstrated that preeclamptic pregnant women in Şanlıurfa exhibited more severe laboratory findings and a higher rate of preeclampsia-related complications compared to those in Bolu.
- 31 March 2026
- Published by Ministry of Health, Ankara City Hospital in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
- Vol. 23 (1) , 49-53
Analysis of Laboratory and Obstetric Outcomes in Preeclampsia: A Comparative Study of Bolu and Şanlıurfa
Aim: The aim of this study is to compare the obstetric outcomes of preeclamptic pregnant women in two different centers.Material andMethod: In this retrospective study, biochemical, hemogram, and obstetric data of pregnant women who presented to obstetrics clinics due to preeclampsia in Şanlıurfa (n=363) and Bolu (n=72) were analyzed.Results: A total of 435 pregnant women diagnosed with preeclampsia were included in the study. No significant differences were observed between Şanlıurfa and Bolu in terms of age, hemoglobin levels, and mode of delivery. However, systolic (SBP) and diastolic (DBP) blood pressures, AST, ALT, gravidity, and parity were significantly higher in Şanlıurfa compared to Bolu. Although proteinuria was more frequently observed in Bolu, it was more severe in Şanlıurfa. Additionally, Rh antigen positivity was found to be more common in preeclamptic pregnancies.Conclusion: Our study demonstrated that preeclamptic pregnant women in Şanlıurfa exhibited more severe laboratory findings and a higher rate of preeclampsia-related complications compared to those in Bolu.
- 23 February 2026
- Published by Elsevier in American Journal of Orthodontics and Dentofacial Orthopedics
- Vol. 169 (6) , 735-743
Short-term effects of type 1 diabetes on new bone formation after rapid maxillary expansion
- 23 February 2026
- Published by Elsevier in American Journal of Orthodontics and Dentofacial Orthopedics
- Vol. 169 (6) , 735-743
Short-term effects of type 1 diabetes on new bone formation after rapid maxillary expansion
- 31 January 2026
- Published by Archives of Current Medical Research in Archives of Current Medical Research
- Vol. 7 (1) , 42-49
Daidzein Inhibits Pentylenetetrazol-Induced Seizures in Mice
Background: Phytomolecules, through their antioxidant and anti-inflammatory effects, can improve neurodegenerative diseases. The aim of this study was to evaluate the effect of daidzein, a phytoestrogenic agent, on seizure severity and oxidative stress in a pentylenetetrazol (PTZ)-induced seizure model. Methods: Male mice were injected intraperitoneally (i.p.) with daidzein (1 and 5 mg/kg) and, 30 minutes later, a single convulsive dose of PTZ was administered. The groups were as follows: PTZ Control, PTZ+Diazepam, PTZ+Daidzein 1 mg/kg, PTZ+Daidzein 5 mg/kg, and PTZ+DMSO. Seizure onset and seizure stages were scored over a 30-minute observation period according to the Racine classification. Serum samples were collected to evaluate oxidative stress parameters using an automated colorimetric method. Results: Administration of daidzein at a dose of 1 mg/kg (first seizure presentation and modified stage p=0.001), but not 5 mg/kg, inhibited seizure formation similarly to diazepam. Neither dose of daidzein (1 and 5 mg/kg) increased serum antioxidant parameters (total thiol (p=0.425), native thiol(p=0.350)). Conclusion: Low-dose daidzein can prevent seizure while causing a smaller increase in oxidative stress parameters compared to diazepam suggests that it may have potential as an anticonvulsant agent.
- 31 January 2026
- Published by Archives of Current Medical Research in Archives of Current Medical Research
- Vol. 7 (1) , 42-49
Daidzein Inhibits Pentylenetetrazol-Induced Seizures in Mice
Background: Phytomolecules, through their antioxidant and anti-inflammatory effects, can improve neurodegenerative diseases. The aim of this study was to evaluate the effect of daidzein, a phytoestrogenic agent, on seizure severity and oxidative stress in a pentylenetetrazol (PTZ)-induced seizure model. Methods: Male mice were injected intraperitoneally (i.p.) with daidzein (1 and 5 mg/kg) and, 30 minutes later, a single convulsive dose of PTZ was administered. The groups were as follows: PTZ Control, PTZ+Diazepam, PTZ+Daidzein 1 mg/kg, PTZ+Daidzein 5 mg/kg, and PTZ+DMSO. Seizure onset and seizure stages were scored over a 30-minute observation period according to the Racine classification. Serum samples were collected to evaluate oxidative stress parameters using an automated colorimetric method. Results: Administration of daidzein at a dose of 1 mg/kg (first seizure presentation and modified stage p=0.001), but not 5 mg/kg, inhibited seizure formation similarly to diazepam. Neither dose of daidzein (1 and 5 mg/kg) increased serum antioxidant parameters (total thiol (p=0.425), native thiol(p=0.350)). Conclusion: Low-dose daidzein can prevent seizure while causing a smaller increase in oxidative stress parameters compared to diazepam suggests that it may have potential as an anticonvulsant agent.
- 30 September 2025
- Published by Ministry of Health, Ankara City Hospital in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
- Vol. 22 (3) , 284-291
Amylin for Diagnosis of Gestational Diabetes Mellitus and Its Association with Advers Obstetric-Neonatal Outcomes
Aim:The aim of the study was to measure serum amylin levels in pregnant women who applied for oral glucose tolerance test(OGTT) between 24-28 weeks,to compare the diagnostic use of amylin in pregnant women with and without a diagnosis of gestational diabetes mellitus(GDM),and to evaluate the relationship between amylin values and obstetric-neonatal outcomes. Material and Methods:The study includes 86 patients selected among 430 pregnant women who applied to the antenatal outpatient clinic for OGTT. 43 of the pregnants whose 50-gr OGTT results were within normal limits; 43 pregnant women who underwent 100-gr OGTT test because their 50-gr OGTT was above 140 mg/dl and diagnosed with GDM because 2 values were defective were determined as the study group.Serum amylin levels were evaluated by matching the control and study groups according to body mass index(BMI). Results:In the study,serum amylin levels were found to be 73.7 in the GDM group and 76.1 in the control group, and there was no significance between the groups(p>0.05). Amylin levels were negatively correlated with age,BMI,gravida,parity in the GDM group,and positively correlated with weight gained and gestational week.There was no statistically significant difference between the groups in terms of obstetric (birth week, birth weight,delivery type,birth trauma) and newborn(NEDCU need) outcomes(p>0.05). Conclusion: Serum amylin concentrations measured before the OGTT do not have a predictive value for the diagnosis of GDM, and serum amylin levels do not predict adverse obstetric and neonatal outcomes.
- 30 September 2025
- Published by Ministry of Health, Ankara City Hospital in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
- Vol. 22 (3) , 284-291
Amylin for Diagnosis of Gestational Diabetes Mellitus and Its Association with Advers Obstetric-Neonatal Outcomes
Aim:The aim of the study was to measure serum amylin levels in pregnant women who applied for oral glucose tolerance test(OGTT) between 24-28 weeks,to compare the diagnostic use of amylin in pregnant women with and without a diagnosis of gestational diabetes mellitus(GDM),and to evaluate the relationship between amylin values and obstetric-neonatal outcomes. Material and Methods:The study includes 86 patients selected among 430 pregnant women who applied to the antenatal outpatient clinic for OGTT. 43 of the pregnants whose 50-gr OGTT results were within normal limits; 43 pregnant women who underwent 100-gr OGTT test because their 50-gr OGTT was above 140 mg/dl and diagnosed with GDM because 2 values were defective were determined as the study group.Serum amylin levels were evaluated by matching the control and study groups according to body mass index(BMI). Results:In the study,serum amylin levels were found to be 73.7 in the GDM group and 76.1 in the control group, and there was no significance between the groups(p>0.05). Amylin levels were negatively correlated with age,BMI,gravida,parity in the GDM group,and positively correlated with weight gained and gestational week.There was no statistically significant difference between the groups in terms of obstetric (birth week, birth weight,delivery type,birth trauma) and newborn(NEDCU need) outcomes(p>0.05). Conclusion: Serum amylin concentrations measured before the OGTT do not have a predictive value for the diagnosis of GDM, and serum amylin levels do not predict adverse obstetric and neonatal outcomes.
- 3 January 2025
- Published by Duzce Universitesi Saglik Bilimleri Enstitusu Dergisi in Sağlık Bilimlerinde Değer
- Vol. 15 (1) , 36-42
Protective Effects of Aronia melanocarpa Extract against Cyclophosphamide-Induced Delayed Toxicity on the Bladder
Aim: Aronia melanocarpa is a red-purple medicinal fruit known for its therapeutic properties in the urinary system by anti-inflammatory effects with high antioxidant content. The aim of the study is to show the supportive effect of Aronia melanocarpa extract delayed toxicity on the bladder induced by cyclophosphamide (CYC) that an antineoplastic agent. Material and Methods: In the study three groups were constituted control (n=7), CYC(urotoxicity group, n=7) and CYC+ARONIA(treatment group, n=7). 100 mg/kg CYC intraperitoneally were given to CYC and CYC+ARONIA groups and waited for 4 weeks to be created delayed toxicity. At the end of the 4 weeks, 200 mg/kg Aronia melanocarpa was administered 15 times by oral gavage every other different day to CYC+ARONIA group (1 month in total). Sacrification was performed and after serum and urine samples were taken, the bladder was released from the sphincter region with curved-tipped forceps. Bladder tissues were investigated histologically. P38 mitogen activated preotein kinase (P38 MAPK), total antioxidant (TAS) and oxidant (TOS) status were evaluated in serum and urine samples. Results: In histology, histological damage in the bladder continued in the CYC group, while Aronia melanocarpa treatment caused healing in the bladder tissue in the CYC+ARONIA group. No difference was found between the groups in terms of P38 MAPK, TAS and TOS in serum and urine samples. Conclusion: According to the experimental results, the fact that Aronia melanocarpa extract improves the histological damage caused by CYC in the delayed period, and the serum and urine findings were the same as the controls, brought up the therapeutic effect of Aronia melanocarpa in urotoxicity.
- 3 January 2025
- Published by Duzce Universitesi Saglik Bilimleri Enstitusu Dergisi in Sağlık Bilimlerinde Değer
- Vol. 15 (1) , 36-42
Protective Effects of Aronia melanocarpa Extract against Cyclophosphamide-Induced Delayed Toxicity on the Bladder
Aim: Aronia melanocarpa is a red-purple medicinal fruit known for its therapeutic properties in the urinary system by anti-inflammatory effects with high antioxidant content. The aim of the study is to show the supportive effect of Aronia melanocarpa extract delayed toxicity on the bladder induced by cyclophosphamide (CYC) that an antineoplastic agent. Material and Methods: In the study three groups were constituted control (n=7), CYC(urotoxicity group, n=7) and CYC+ARONIA(treatment group, n=7). 100 mg/kg CYC intraperitoneally were given to CYC and CYC+ARONIA groups and waited for 4 weeks to be created delayed toxicity. At the end of the 4 weeks, 200 mg/kg Aronia melanocarpa was administered 15 times by oral gavage every other different day to CYC+ARONIA group (1 month in total). Sacrification was performed and after serum and urine samples were taken, the bladder was released from the sphincter region with curved-tipped forceps. Bladder tissues were investigated histologically. P38 mitogen activated preotein kinase (P38 MAPK), total antioxidant (TAS) and oxidant (TOS) status were evaluated in serum and urine samples. Results: In histology, histological damage in the bladder continued in the CYC group, while Aronia melanocarpa treatment caused healing in the bladder tissue in the CYC+ARONIA group. No difference was found between the groups in terms of P38 MAPK, TAS and TOS in serum and urine samples. Conclusion: According to the experimental results, the fact that Aronia melanocarpa extract improves the histological damage caused by CYC in the delayed period, and the serum and urine findings were the same as the controls, brought up the therapeutic effect of Aronia melanocarpa in urotoxicity.
- Open Access
- 29 October 2024
- Published by MediHealth Academy in Academic Journal of Neurology and Neurosurgery
- Vol. 1 (4) , 68-72
The impact of high dose corticosteroid treatment affect on cardiac abnormalities in patients with multiple sclerosis
Aims: High-dose corticosteroids to control acute relapses of multiple sclerosis, leveraging their anti-inflammatory effects. However, these treatments can lead to cardiovascular side effects. Understanding the pathophysiology of corticosteroid induced bradycardia is paramount for healthcare providers. Our aim in this study are to identify risk factors for cardiac side effects and assess the timing of cardiac complications relative to treatment. Methods: Patients who met the McDonald's criteria for definite MS and patients requiring admission for pulse steroid treatment with an acute recurrence were included.Individuals taking cardiac medications, or with a heart illness were excluded.Patients were given 1 g IV methylprednisolone in 2 hours for five to seven days in order to treat acute relapses. Results: We studied with 23 patients(6 males and 17 females, 26.1/73.9% respectively).The mean±SD age of the patients was 34.6±9.9 (18-43) years and the mean±SD duration of disease was 5.5±4.9 years.Most of the patients were relapsing–remitting MS in 73.9%, primary progressive in 4.4% and secondary progressive in 21.7%.The most common cardiac arhythmia during corticosteroid pulse therapy was sinus bradycradia(n=6). Conclusion: The combination of direct effects on cardiac myocytes, electrolyte disturbances, autonomic dysfunction, and individual genetic factors can contribute to the development of bradycardia in MS patients treated with high-dose methylprednisolone. Close monitoring and prompt intervention are crucial to manage this adverse effect and optimize patient safety.
- 29 October 2024
- Published by MediHealth Academy in Academic Journal of Neurology and Neurosurgery
- Vol. 1 (4) , 68-72
Open AccessThe impact of high dose corticosteroid treatment affect on cardiac abnormalities in patients with multiple sclerosis
Aims: High-dose corticosteroids to control acute relapses of multiple sclerosis, leveraging their anti-inflammatory effects. However, these treatments can lead to cardiovascular side effects. Understanding the pathophysiology of corticosteroid induced bradycardia is paramount for healthcare providers. Our aim in this study are to identify risk factors for cardiac side effects and assess the timing of cardiac complications relative to treatment. Methods: Patients who met the McDonald's criteria for definite MS and patients requiring admission for pulse steroid treatment with an acute recurrence were included.Individuals taking cardiac medications, or with a heart illness were excluded.Patients were given 1 g IV methylprednisolone in 2 hours for five to seven days in order to treat acute relapses. Results: We studied with 23 patients(6 males and 17 females, 26.1/73.9% respectively).The mean±SD age of the patients was 34.6±9.9 (18-43) years and the mean±SD duration of disease was 5.5±4.9 years.Most of the patients were relapsing–remitting MS in 73.9%, primary progressive in 4.4% and secondary progressive in 21.7%.The most common cardiac arhythmia during corticosteroid pulse therapy was sinus bradycradia(n=6). Conclusion: The combination of direct effects on cardiac myocytes, electrolyte disturbances, autonomic dysfunction, and individual genetic factors can contribute to the development of bradycardia in MS patients treated with high-dose methylprednisolone. Close monitoring and prompt intervention are crucial to manage this adverse effect and optimize patient safety.
- Open Access
- 30 June 2024
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- Vol. 26 (S1) , 30-35
Anesthesia Applications In Experimental Neurological Disease Modeling
Neuroscience, which covers the molecular mechanisms employed by the brain to cause neurological diseases and how they can be treated, remains current as the subject of high-budget investigations to develop early diagnosis and new treatment modalities with multidisciplinary approaches. For this purpose, creating the appropriate model with the correct modality and anesthesia in neurological in vivo experimental models is the most important phase to obtain accurate results and ensure animal welfare. To manage anesthesia in rodents, knowing the physiological characteristics of anesthetics and their risks will strengthen experimental procedures. Among the injectable anesthetics, ketamine, xylazine, and pentobarbital are the most frequently preferred agents for general anesthesia in short surgical procedures. Isoflurane and sevoflurane are inhaler anesthetics that are administered through a vaporizer because they are liquids. Important advantages of inhaled anesthetics, such as rapid induction and rapid withdrawal, make inhaled anesthetics stand out in neuroscience studies. In this review, the properties of frequently used anesthetic agents in rodents, their usage methods, and which model they are preferred will be discussed. For this purpose, the selection of appropriate anesthetics in animal models such as epilepsy, Alzheimer's disease, ischemia-reperfusion injury, traumatic brain injury, ischemic stroke, experimental autoimmune encephalomyelitis, and ophthalmic surgical procedures and their side effects will be reviewed.
- 30 June 2024
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- Vol. 26 (S1) , 30-35
Open AccessAnesthesia Applications In Experimental Neurological Disease Modeling
Neuroscience, which covers the molecular mechanisms employed by the brain to cause neurological diseases and how they can be treated, remains current as the subject of high-budget investigations to develop early diagnosis and new treatment modalities with multidisciplinary approaches. For this purpose, creating the appropriate model with the correct modality and anesthesia in neurological in vivo experimental models is the most important phase to obtain accurate results and ensure animal welfare. To manage anesthesia in rodents, knowing the physiological characteristics of anesthetics and their risks will strengthen experimental procedures. Among the injectable anesthetics, ketamine, xylazine, and pentobarbital are the most frequently preferred agents for general anesthesia in short surgical procedures. Isoflurane and sevoflurane are inhaler anesthetics that are administered through a vaporizer because they are liquids. Important advantages of inhaled anesthetics, such as rapid induction and rapid withdrawal, make inhaled anesthetics stand out in neuroscience studies. In this review, the properties of frequently used anesthetic agents in rodents, their usage methods, and which model they are preferred will be discussed. For this purpose, the selection of appropriate anesthetics in animal models such as epilepsy, Alzheimer's disease, ischemia-reperfusion injury, traumatic brain injury, ischemic stroke, experimental autoimmune encephalomyelitis, and ophthalmic surgical procedures and their side effects will be reviewed.
- Open Access
- 30 January 2024
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 4 (1) , 7-13
Does cerebrospinal fluid IL-17F distinguish normal pressure hydrocephalus from dementia?
Aim: The neurological disorder known as normal pressure hydrocephalus (NPH), which has an unknown cause, may be treatable, and is defined by a clinical triad of symptoms. A phenomenon known as dementia refers to a decline in cognitive performance that goes beyond what may be anticipated from the typical effects of biological aging. The symptomatic similarity between these two diseases causes problems in diagnosis. The objective of our study was to compare the concentrations of IL-17A, IL-17F, IL-34, and CXCL13 in the cerebrospinal fluid (CSF) of patients with NPH and dementia for an informative laboratory diagnosis. Methods: The study included NPH and dementia cases (n=7, n=5, respectively) taken from the patients’s CSF sample by lumbar puncture (LP). The levels of IL-17A, IL-17F, IL-34, and CXCL13 were measured in the CSF of patients' with NPH and dementia by enzyme-linked assay (ELISA) and compared between the two different groups. Results: There was no difference in age between the NPH and dementia groups (p=0.5). There was no statistically significant difference was found in IL-17A (p=0.7), IL-34 (p=0.9), and CXCL13 (p=0.2) in the inflammatory marker analysis in the CSF. The groups had a statistically significant difference in IL-17F (p=0.04). Conclusion: IL-17F can be an important laboratory marker used in the differential diagnosis of NPH and dementia.
- 30 January 2024
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 4 (1) , 7-13
Open AccessDoes cerebrospinal fluid IL-17F distinguish normal pressure hydrocephalus from dementia?
Aim: The neurological disorder known as normal pressure hydrocephalus (NPH), which has an unknown cause, may be treatable, and is defined by a clinical triad of symptoms. A phenomenon known as dementia refers to a decline in cognitive performance that goes beyond what may be anticipated from the typical effects of biological aging. The symptomatic similarity between these two diseases causes problems in diagnosis. The objective of our study was to compare the concentrations of IL-17A, IL-17F, IL-34, and CXCL13 in the cerebrospinal fluid (CSF) of patients with NPH and dementia for an informative laboratory diagnosis. Methods: The study included NPH and dementia cases (n=7, n=5, respectively) taken from the patients’s CSF sample by lumbar puncture (LP). The levels of IL-17A, IL-17F, IL-34, and CXCL13 were measured in the CSF of patients' with NPH and dementia by enzyme-linked assay (ELISA) and compared between the two different groups. Results: There was no difference in age between the NPH and dementia groups (p=0.5). There was no statistically significant difference was found in IL-17A (p=0.7), IL-34 (p=0.9), and CXCL13 (p=0.2) in the inflammatory marker analysis in the CSF. The groups had a statistically significant difference in IL-17F (p=0.04). Conclusion: IL-17F can be an important laboratory marker used in the differential diagnosis of NPH and dementia.